Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity.

S Dische1, M I Saunders

  • 1Regional Centre for Radiotherapy and Oncology, Mount Vernon Hospital, Northwood, Middlesex, U.K.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|September 1, 1989
PubMed
Summary

Continuous, hyperfractionated, accelerated radiotherapy (CHART) shows promise for advanced head and neck and bronchial cancers. However, rare cases of radiation myelitis necessitate careful dose adjustments to mitigate spinal cord damage risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To restore coastal marine areas, we need to work across multiple habitats simultaneously.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Impact of sea-level rise and coral mortality on the wave dynamics and wave forces on barrier reefs.

Marine pollution bulletin·2014
Same author

Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2010
Same author

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans.

British journal of cancer·2009

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Continuous, hyperfractionated, accelerated radiotherapy (CHART) is an advanced radiation therapy technique.
  • CHART aims to improve tumor control while minimizing side effects compared to conventional radiotherapy.
  • This technique has shown efficacy in treating advanced head and neck and bronchial carcinomas.

Observation:

  • While late side effects generally appear reduced with CHART compared to conventional radiotherapy,
  • two cases of radiation myelitis (spinal cord inflammation) were observed.
  • This occurred despite predictions of a lower risk of spinal cord damage with the CHART protocol.

Findings:

  • The observed cases of radiation myelitis suggest a potential risk associated with CHART, even with dose reduction predictions.

Related Experiment Videos

  • Analysis of the potential causes for these myelitis cases is crucial for understanding the underlying mechanisms.
  • The findings led to a reduction in the permitted spinal cord dose for CHART protocols.

    • Implications:

    • The findings underscore the importance of ongoing monitoring and risk assessment in advanced radiotherapy techniques.
    • Adjusting spinal cord dose limits is a critical safety measure to prevent severe neurological complications.
    • Further research may be needed to optimize CHART parameters for maximum efficacy and safety in treating thoracic and head/neck cancers.